当前位置: 首页 > 期刊 > 《中国中药杂志》 > 2014年第1期
编号:13144738
中药市场应慎用“降价令”——基于统计资料的分析(4)
http://www.100md.com 2014年1月1日 《中国中药杂志》 2014年第1期
     2.National Resource Center for Chinese Materia Medica, China Academy of Chinese Medicinal Sciences, Beijing 100700, China;

    3.School of Economics and Resource Management, Beijing Normal University, Beijing 100875, China;

    4. Ningxia Medical University, Yinchuan 750004, China)

    [Abstract] A dispute about the decreasing-price problem of traditional Chinese medicine (TCM) has recently arisen. This article analyzes the statistical data of 1995—2011 in China, the results showed that the main responsibility of expensive health care has no direct relationship with the drug price. The price index of TCM rose significantly slower than the medicine prices, the production margins of TCM affected by the material prices has been diminishing since 1995, continuous price reduction will further depress profits of the TCM industry. Considering the pros and cons of raw materials vary greatly in price, decreasing medicine price behavior will force enterprises to use inferior materials in order to maintain corporate profits. The results have the guiding meaning to medicine price management.

    [Key words] traditional Chinese medicine; price controls; the quality of traditional Chinese medicine; per capita drug costs; price index

    doi:10.4268/cjcmm20140127

    [责任编辑 吕冬梅], http://www.100md.com(杨光 王诺 黄璐琦 邱红燕 郭兰萍)
上一页1 2 3 4